• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Repeated Treatments with Chitosan in Combination with Antibiotics Completely Eradicate Uropathogenic Escherichia coli From Infected Mouse Urinary Bladders.壳聚糖与抗生素联合重复治疗可完全清除感染小鼠膀胱中的尿路致病性大肠杆菌。
J Infect Dis. 2017 Aug 1;216(3):375-381. doi: 10.1093/infdis/jix023.
2
Forced resurgence and targeting of intracellular uropathogenic Escherichia coli reservoirs.强制复苏和靶向细胞内尿路致病性大肠杆菌储库。
PLoS One. 2014 Mar 25;9(3):e93327. doi: 10.1371/journal.pone.0093327. eCollection 2014.
3
Plant phenolics inhibit focal adhesion kinase and suppress host cell invasion by uropathogenic .植物酚类物质通过尿路致病性抑制黏着斑激酶并抑制宿主细胞侵袭。
Infect Immun. 2024 May 7;92(5):e0008024. doi: 10.1128/iai.00080-24. Epub 2024 Mar 27.
4
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.面对多种抗生素,尿路致病性大肠杆菌仍持续存在。
Antimicrob Agents Chemother. 2010 May;54(5):1855-63. doi: 10.1128/AAC.00014-10. Epub 2010 Mar 15.
5
Intracellular uropathogenic Escherichia coli are undetectable in urinary bladders after oral mecillinam treatment: An experimental study in a pig model of cystitis.口服美西林治疗后,尿路上皮细胞内尿路致病性大肠埃希菌不可检测:膀胱炎猪模型的实验研究。
Microb Pathog. 2022 Dec;173(Pt A):105817. doi: 10.1016/j.micpath.2022.105817. Epub 2022 Oct 14.
6
Persistence of uropathogenic Escherichia Coli in the bladders of female patients with sterile urine after antibiotic therapies.抗生素治疗后无菌尿女性患者膀胱中尿路致病性大肠杆菌的持续存在。
J Huazhong Univ Sci Technolog Med Sci. 2016 Oct;36(5):710-715. doi: 10.1007/s11596-016-1649-9. Epub 2016 Oct 18.
7
Oral supplementation of trans-cinnamaldehyde reduces uropathogenic Escherichia coli colonization in a mouse model.口服反式肉桂醛可减少小鼠模型中尿路致病性大肠杆菌的定植。
Lett Appl Microbiol. 2017 Mar;64(3):192-197. doi: 10.1111/lam.12713. Epub 2017 Jan 28.
8
Effect of trimethoprim-sulfamethoxazole on recurrent bacteriuria and bacterial persistence in mice infected with uropathogenic Escherichia coli.甲氧苄啶-磺胺甲恶唑对感染尿路致病性大肠杆菌的小鼠复发性菌尿和细菌持续性感染的影响。
Infect Immun. 2002 Dec;70(12):7042-9. doi: 10.1128/IAI.70.12.7042-7049.2002.
9
A non-canonical autophagy-dependent role of the ATG16L1 variant in urothelial vesicular trafficking and uropathogenic Escherichia coli persistence.ATG16L1 变异体在非经典自噬依赖性中的作用:对尿路上皮囊泡运输和尿路致病性大肠杆菌持续存在的影响。
Autophagy. 2019 Mar;15(3):527-542. doi: 10.1080/15548627.2018.1535290. Epub 2018 Nov 8.
10
Intramacrophage survival of uropathogenic Escherichia coli: differences between diverse clinical isolates and between mouse and human macrophages.尿路致病性大肠杆菌在巨噬细胞内的存活:不同临床分离株之间以及小鼠和人巨噬细胞之间的差异。
Immunobiology. 2011 Nov;216(11):1164-71. doi: 10.1016/j.imbio.2011.05.011. Epub 2011 May 24.

引用本文的文献

1
Efficacy and Safety of Uro-Vaxom in Urinary Tract Infection Prevention: A Systematic Literature Review.Uro-Vaxom预防尿路感染的疗效与安全性:一项系统文献综述
J Clin Med. 2025 May 29;14(11):3836. doi: 10.3390/jcm14113836.
2
Novel Fabrication of Bio-polymeric Nanogel Loaded with Nalidixic Acid Formulations for the Effective Prevention of Bacterial Pathogens Leading Urinary Tract Infection and Its Biosafety Evaluation.新型载萘啶酸生物聚合物纳米凝胶的制备及其用于有效预防导致尿路感染的细菌病原体的制剂及其生物安全性评价。
Curr Microbiol. 2024 Sep 6;81(10):347. doi: 10.1007/s00284-024-03863-x.
3
A magnetic hydrogel for the efficient retrieval of kidney stone fragments during ureteroscopy.一种用于输尿管镜取石术中高效回收肾结石碎片的磁性水凝胶。
Nat Commun. 2023 Jun 22;14(1):3711. doi: 10.1038/s41467-023-38936-1.
4
A Biomimetic Porcine Urothelial Model for Assessing Pathogenicity.一种用于评估致病性的仿生猪膀胱上皮模型。
Microorganisms. 2022 Apr 7;10(4):783. doi: 10.3390/microorganisms10040783.
5
Antimicrobial Actions and Applications of Chitosan.壳聚糖的抗菌作用及应用
Polymers (Basel). 2021 Mar 15;13(6):904. doi: 10.3390/polym13060904.
6
Current Trends in Experimental and Computational Approaches to Combat Antimicrobial Resistance.对抗抗菌药物耐药性的实验与计算方法的当前趋势
Front Genet. 2020 Nov 6;11:563975. doi: 10.3389/fgene.2020.563975. eCollection 2020.
7
Does the Urothelium of Old Mice Regenerate after Chitosan Injury as Quickly as the Urothelium of Young Mice?老年小鼠的尿路上皮在壳聚糖损伤后能像年轻小鼠一样快速再生吗?
Int J Mol Sci. 2020 May 15;21(10):3502. doi: 10.3390/ijms21103502.
8
Poly-L-lysine as an Effective and Safe Desquamation Inducer of Urinary Bladder Epithelium.聚-L-赖氨酸作为膀胱上皮有效的安全的脱屑诱导剂
Polymers (Basel). 2019 Sep 16;11(9):1506. doi: 10.3390/polym11091506.
9
Nanomaterials as Delivery Vehicles and Components of New Strategies to Combat Bacterial Infections: Advantages and Limitations.纳米材料作为对抗细菌感染新策略的递送载体和组成部分:优势与局限
Microorganisms. 2019 Sep 16;7(9):356. doi: 10.3390/microorganisms7090356.
10
The Use of Polymer Chitosan in Intravesical Treatment of Urinary Bladder Cancer and Infections.聚合物壳聚糖在膀胱肿瘤及感染膀胱内治疗中的应用
Polymers (Basel). 2018 Mar 5;10(3):265. doi: 10.3390/polym10030265.

本文引用的文献

1
The Vaccine Adjuvant Chitosan Promotes Cellular Immunity via DNA Sensor cGAS-STING-Dependent Induction of Type I Interferons.疫苗佐剂壳聚糖通过DNA传感器cGAS-STING依赖性诱导I型干扰素促进细胞免疫。
Immunity. 2016 Mar 15;44(3):597-608. doi: 10.1016/j.immuni.2016.02.004. Epub 2016 Mar 2.
2
Forced resurgence and targeting of intracellular uropathogenic Escherichia coli reservoirs.强制复苏和靶向细胞内尿路致病性大肠杆菌储库。
PLoS One. 2014 Mar 25;9(3):e93327. doi: 10.1371/journal.pone.0093327. eCollection 2014.
3
Urinary tract infections: current and emerging management strategies.尿路感染:当前和新兴的管理策略。
Clin Infect Dis. 2013 Sep;57(5):719-24. doi: 10.1093/cid/cit284. Epub 2013 May 3.
4
Correlative study of functional and structural regeneration of urothelium after chitosan-induced injury.壳聚糖诱导损伤后尿路上皮功能和结构再生的相关性研究。
Histochem Cell Biol. 2013 Nov;140(5):521-31. doi: 10.1007/s00418-013-1088-7. Epub 2013 Apr 4.
5
Effects of pH on molecular mechanisms of chitosan-integrin interactions and resulting tight-junction disruptions.pH 对壳聚糖-整合素相互作用的分子机制及其导致的紧密连接破坏的影响。
Biomaterials. 2013 Jan;34(3):784-93. doi: 10.1016/j.biomaterials.2012.09.082. Epub 2012 Oct 24.
6
Elucidating the signaling mechanism of an epithelial tight-junction opening induced by chitosan.阐明壳聚糖诱导上皮紧密连接开放的信号机制。
Biomaterials. 2012 Sep;33(26):6254-63. doi: 10.1016/j.biomaterials.2012.05.013. Epub 2012 Jun 7.
7
Urinary tract infections in women.女性下尿路感染。
Med Clin North Am. 2011 Jan;95(1):27-41. doi: 10.1016/j.mcna.2010.08.023.
8
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.面对多种抗生素,尿路致病性大肠杆菌仍持续存在。
Antimicrob Agents Chemother. 2010 May;54(5):1855-63. doi: 10.1128/AAC.00014-10. Epub 2010 Mar 15.
9
Chitosan-based systems for the delivery of vaccine antigens.用于递送疫苗抗原的基于壳聚糖的系统。
Expert Rev Vaccines. 2009 Jul;8(7):937-53. doi: 10.1586/erv.09.47.
10
Rapid differentiation of superficial urothelial cells after chitosan-induced desquamation.壳聚糖诱导脱落后浅表尿路上皮细胞的快速分化
Histochem Cell Biol. 2009 Jan;131(1):129-39. doi: 10.1007/s00418-008-0492-x. Epub 2008 Sep 17.

壳聚糖与抗生素联合重复治疗可完全清除感染小鼠膀胱中的尿路致病性大肠杆菌。

Repeated Treatments with Chitosan in Combination with Antibiotics Completely Eradicate Uropathogenic Escherichia coli From Infected Mouse Urinary Bladders.

作者信息

Erman Andreja, Hergouth Veronika Križan, Blango Matthew G, Kos Mojca Kerec, Mulvey Matthew A, Veranic Peter

机构信息

Institute of Cell Biology, Faculty of Medicine, University of Ljubljana, Slovenia.

Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Slovenia.

出版信息

J Infect Dis. 2017 Aug 1;216(3):375-381. doi: 10.1093/infdis/jix023.

DOI:10.1093/infdis/jix023
PMID:28119486
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5853829/
Abstract

Uropathogenic Escherichia coli (UPEC), the primary causative agents of urinary tract infections, colonize and invade the epithelial cells of the bladder urothelium. Infection of immature urothelial cells can result in the formation of persistent intracellular reservoirs that are refractory to antibiotic treatments. Previously, we defined a novel therapeutic strategy that used the bladder cell exfoliant chitosan to deplete UPEC reservoirs. However, although a single treatment of chitosan followed by ciprofloxacin administration had a marked effect on reducing UPEC titers within the bladder, this treatment failed to prevent relapsing bacteriuria. We show here that repeated use of chitosan in conjunction with the antibiotic ciprofloxacin completely eradicates UPEC from the urinary tract and prevents the development of relapsing bouts of bacteriuria. In addition, microscopy revealed rapid restoration of bladder integrity following chitosan treatment, indicating that chitosan can be used to effectively combat recalcitrant bladder infections without causing lasting harm to the urothelium.

摘要

尿路致病性大肠杆菌(UPEC)是尿路感染的主要病原体,可定植并侵入膀胱尿路上皮的上皮细胞。未成熟尿路上皮细胞的感染可导致形成对抗生素治疗具有抗性的持续性细胞内菌库。此前,我们定义了一种新的治疗策略,即使用膀胱细胞脱落剂壳聚糖来清除UPEC菌库。然而,尽管单次使用壳聚糖后再给予环丙沙星对降低膀胱内的UPEC滴度有显著效果,但这种治疗未能预防复发性菌尿。我们在此表明,重复使用壳聚糖并联合抗生素环丙沙星可从尿路中完全根除UPEC,并预防复发性菌尿的发生。此外,显微镜检查显示壳聚糖治疗后膀胱完整性迅速恢复,这表明壳聚糖可用于有效对抗难治性膀胱感染,而不会对尿路上皮造成持久损害。